Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FLGNX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,567
Award facts
- Contract value 100% obligated
- $41,566.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,566.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, issued on August 22, 2025, carries an ultimate completion date of September 15, 2025, and represents no set-aside designation. The award falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with DLA valued at $499.9 million through November 2026, which authorizes the issuance of delivery orders for an extensive range of pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to secure consistent contracts with the Defense Logistics Agency. The company specializes in distributing branded and generic prescription drugs, biologics, and specialized medical consumables to Department of Defense healthcare sites. Entyvio, a gastrointestinal biologic therapy, represents one of numerous pharmaceutical products the contractor supplies through its comprehensive distribution network to support military medical operations and personnel healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FLGNX?
SPE2DB25FLGNX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FLGNX worth?
The government has obligated $41,567 on SPE2DB25FLGNX.
Is contract SPE2DB25FLGNX an order under another contract?
Yes. SPE2DB25FLGNX is a delivery order under SPE2DB24D9644, an indefinite delivery contract.
Was contract SPE2DB25FLGNX competed?
The extent of competition for SPE2DB25FLGNX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award